Active, Not Recruiting
Study of Brexucabtagene Autoleucel Plus Dasatinib in Adults With Acute Lymphoblastic Leukemia
NCT05993949
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Stanford University Palo Alto, California, United States